These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 6237116)
41. Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility. Viguier-Martinez MC; Hochereau de Reviers MT; Barenton B; Perreau C Acta Endocrinol (Copenh); 1983 Oct; 104(2):246-52. PubMed ID: 6314726 [TBL] [Abstract][Full Text] [Related]
42. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone. Gross KM; Matsumoto AM; Southworth MB; Bremner WJ J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266 [TBL] [Abstract][Full Text] [Related]
43. Similarities and differences in progesterone and androgens in modulation of LH, FSH and PRL release: unexpected properties of flutamide. Brann DW; Putnam CD; Mahesh VB J Steroid Biochem; 1990 Jul; 36(4):287-94. PubMed ID: 2118203 [TBL] [Abstract][Full Text] [Related]
44. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897 [TBL] [Abstract][Full Text] [Related]
45. The effect of short term treatment with cyproterone acetate or flutamide on the metabolism of 5 alpha-dihydrotestosterone in human testicular tissue. Tamm J; Volkwein U; Donn F J Steroid Biochem; 1988 Aug; 31(2):251-2. PubMed ID: 2970000 [TBL] [Abstract][Full Text] [Related]
46. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. Wang C; Tso SC; Todd D J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034 [TBL] [Abstract][Full Text] [Related]
47. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass. López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346 [TBL] [Abstract][Full Text] [Related]
48. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [TBL] [Abstract][Full Text] [Related]
49. Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat. Chandolia RK; Weinbauer GF; Simoni M; Behre HM; Nieschlag E Acta Endocrinol (Copenh); 1991 Nov; 125(5):547-55. PubMed ID: 1759544 [TBL] [Abstract][Full Text] [Related]
50. Effects of castration and chronic steroid treatments on hypothalamic gonadotropin-releasing hormone content and pituitary gonadotropins in male wild-type and estrogen receptor-alpha knockout mice. Lindzey J; Wetsel WC; Couse JF; Stoker T; Cooper R; Korach KS Endocrinology; 1998 Oct; 139(10):4092-101. PubMed ID: 9751487 [TBL] [Abstract][Full Text] [Related]
51. Gonadotropin-releasing hormone increases the amount of messenger ribonucleic acid for gonadotropins in ovariectomized ewes after hypothalamic-pituitary disconnection. Hamernik DL; Nett TM Endocrinology; 1988 Mar; 122(3):959-66. PubMed ID: 2449345 [TBL] [Abstract][Full Text] [Related]
52. Longitudinal study of the behaviour of certain hormonal parameters in women undergoing treatment with cyproterone acetate. Giusti M; Parazzi F; Reitano A; Bolognesi F; Giordano G Acta Eur Fertil; 1977 Sep; 8(3):211-28. PubMed ID: 200047 [TBL] [Abstract][Full Text] [Related]
53. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. Bouchard P; Lagoguey M; Brailly S; Schaison G J Clin Endocrinol Metab; 1985 Feb; 60(2):258-62. PubMed ID: 3917455 [TBL] [Abstract][Full Text] [Related]
54. Pituitary gonadotropin-releasing hormone (GnRH) receptor responses to GnRH in hypothalamus-lesioned rats: inhibition of responses by hyperprolactinemia and evidence that testosterone and estradiol modulate gonadotropin secretion at postreceptor sites. Pieper DR; Gala RR; Schiff MA; Regiani SR; Marshall JC Endocrinology; 1984 Sep; 115(3):1190-6. PubMed ID: 6086288 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens. O'Connor JC; Frame SR; Ladics GS Toxicol Sci; 2002 Sep; 69(1):92-108. PubMed ID: 12215663 [TBL] [Abstract][Full Text] [Related]
56. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol. Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934 [TBL] [Abstract][Full Text] [Related]
57. The effect of androgen blockade on pulsatile gonadotrophin release and LH response to naloxone. Balzano S; Migliari R; Sica V; Scarpa RM; Pintus C; Loviselli A; Usai E; Balestrieri A Clin Endocrinol (Oxf); 1987 Oct; 27(4):491-9. PubMed ID: 3124993 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate. Poyet P; Labrie F Mol Cell Endocrinol; 1985 Oct; 42(3):283-8. PubMed ID: 3930312 [TBL] [Abstract][Full Text] [Related]